Sunday, January 23, 2011
Blog posts on Federal Circuit's joint infringement opinion Akamai v. Limelight
Direct infringement generally requires a single infringer, though joint infringement is a theoretical possibility. Joint infringement has always been a tough theory to win on, and the Federal Circuit just made it harder. In the recent decision Akamai vs. Limelight, the Federal Circuit held that there can "only be joint infringement when there is an agency relationship between the parties who perform the method steps or when one party is contractually obligated to the other to perform the steps."
I found a couple of interesting posts from other bloggers that explore the practical implications of Akamai. Most joint infringement cases I'm aware of relate to software, but PharmaPatents takes a different angle and looks here at how Akamai might be applied to diagnostic medical methods. Gametime IP makes the case here that divided infringement is a concern for system/apparatus claims as well as method claims like those at issue in Akamai.